Cartesian Growth Corporation IV closed at $9.79 on Nov 6, up 0.20%, within 0.2% of its lowest close since Sep 14. Volume of 115.6K shares was 3.55× its 20-day average (well above normal).
Split-adjusted performance: -0.2% over one month.
Short interest was 76 shares at the Oct 15 settlement, down 68.6% from the prior report (0.0% of float, 1.0 days to cover).
No reported quarters with price history yet.
Percentile among 171 companies (100 = best)
Industry medians: 6-month return +1.8%, revenue growth −2.0%, net margin −70.6%, P/E 41.4×.
| Company | Price | Today | 6M | Rev. growth | Net margin | P/E | Mkt cap | |
|---|---|---|---|---|---|---|---|---|
| CGCFCartesian Growth Corporation IV | $9.79 | +0.20% | — | — | — | — | $269.2M | |
| DNMXDynamix Corporation III | $10.11 | −0.10% | +1.3% | — | — | — | $271.3M | Compare |
| XTERXterax Corporation II | $9.78 | +0.10% | — | — | — | — | $267.2M | Compare |
| CATLCatalyst Acquisition | $9.80 | −0.19% | — | — | — | — | $266.1M | Compare |
| DMAADrugs Made In America Acquisition | $10.89 | 0.00% | +2.7% | — | — | — | $264.4M | Compare |
| CEPOCantor Equity Partners I | $10.80 | 0.00% | +2.2% | — | — | — | $275.4M | Compare |
| OACCOaktree Acquisition Corp. III Life Sciences | $10.70 | −0.19% | +0.8% | — | — | — | $263.0M | Compare |
| VNMEVendome Acquisition Corporation I | $10.35 | +0.29% | — | — | — | — | $258.8M | Compare |
| PAIIPyrophyte Acquisition Corp. II | $10.35 | 0.00% | +2.0% | — | — | — | $282.2M | Compare |
No recent articles focused on Cartesian Growth Corporation IV.
Cartesian Growth Corp IV is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology